MRI and 1H MRS of The Breast: Presence of a Choline Peak as Malignancy Marker is Related to k21 Value of the Tumor in Patients with Invasive Ductal Carcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Breast Journal

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4741.2008.00650.xPMID 19000051PMCID PMC2842578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MR spectroscopy of the breast

  2008cited by this paper
• Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.

  2006cited by this paper
• Imaging in breast cancer: Magnetic resonance spectroscopy

  2005cited by this paper
• Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T

  2005cited by this paper
• Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study

  2005cited by this paper
• Contrast‐enhanced MRI of ductal carcinoma in situ: Characteristics of a new intensity‐modulated parametric mapping technique correlated with histopathologic findings

  2005cited by this paper
• Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

  2004cited by this paper
• Breast MRI for women with hereditary cancer risk.

  2004cited by this paper
• Characterization of breast lesions with proton MR spectroscopy.

  2003cited by this paper
• Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.

  2003cited by this paper
• Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.

  2002cited by this paper
• Breast lesions detected on MR imaging: features and positive predictive value.

  2002cited by this paper
• MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.

  2001cited by this paper
• Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

  2001cited by this paper
• Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data.

  2001cited by this paper
• Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies

  2001cited by this paper
• Pathophysiologic basis of contrast enhancement in breast tumors

  1999cited by this paper
• Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy

  1999cited by this paper
• Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors.

  1999cited by this paper
• Breast disease: dynamic spiral MR imaging.

  1998cited by this paper
• In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil

  1998cited by this paper
• Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing)

  1997cited by this paper
• Nuclear magnetic resonance spectroscopy of cancer.

  1997cited by this paper
• MR spectroscopy of the breast.

  1994cited by this paper
• MR spectroscopy of the breast.

  1994cited by this paper

• Magnetic Resonance Spectroscopy Findings of Intracranial Chondroma and Chondrosarcoma with a Non-Skull Base Origin: A Report of Two Cases

  2023cites this paper
• Novel Technologies in Breast Imaging: A Scoping Review

  2023influential citation
• Diagnostic Performance of Proton Magnetic Resonance Spectroscopy and 18F-Fluorocholine PET to Differentiate Benign From Malignant Breast Lesions

  2021cites this paper
• Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer

  2020cites this paper
• Differential diagnosis of plasma cell mastitis and invasive ductal carcinoma using multiparametric MRI.

  2020cites this paper
• Role of Recent MR Imaging Modalities in Diagnosis of Problematic Breast Lesions

  2018cites this paper
• Imaging Cancer Metabolism

  2017cites this paper
• Response to “Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing breast tumors”

  2014cites this paper
• 3.19 – MRS of the Breast

  2014cites this paper
• In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature

  2012cites this paper
• Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.

  2011cites this paper
• Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.

  2011cites this paper
• The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging

  2011cites this paper
• Quantifying total choline-containing compounds in breast tumors by 1H MR spectroscopy using external reference solution at 1.5 T: Can it improve specificity for differentiating benign and malignant lesions on MR imaging?

  2011cites this paper
• Quantitative multivoxel proton chemical shift imaging of the breast.

  2010cites this paper
• The Necrosis Sign in Magnetic Resonance‐Mammography: Diagnostic Accuracy in 1,084 Histologically Verified Breast Lesions

  2010cites this paper
• Imaging and ‘omic’ methods for the molecular diagnosis of cancer

  2010cites this paper
• Combined DCE‐MRI and single‐voxel 2D MRS for differentiation between benign and malignant breast lesions

  2010cites this paper
• Breast Magnetic Resonance Spectroscopy (MRS)

  2009cites this paper
• Spectroscopic Imaging of Breast Cancer

  2009cites this paper